Bristol-Myers Board Urged to Fire CEO Dolan A federal monitor overseeing drug maker Bristol-Myers Squibb Co. has urged the firing of CEO Peter Dolan and the company's general counsel, according to a source familiar with the situation. Bristol-Myers' board is expected to consider cutting the company's hefty dividend Tuesday, according to sources.
NPR logo

Bristol-Myers Board Urged to Fire CEO Dolan

  • Download
  • <iframe src="https://www.npr.org/player/embed/6062902/6062903" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Bristol-Myers Board Urged to Fire CEO Dolan

Bristol-Myers Board Urged to Fire CEO Dolan

Bristol-Myers Board Urged to Fire CEO Dolan

  • Download
  • <iframe src="https://www.npr.org/player/embed/6062902/6062903" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

A federal monitor overseeing drug maker Bristol-Myers Squibb Co. has urged that CEO Peter Dolan and the company's general counsel be fired, according to a source familiar with the situation.

Bristol-Myers' board is expected to consider cutting the company's hefty dividend Tuesday, according to sources.

Dolan has been criticized for a series of missteps, including an accounting scandal, overpaying in a deal with biotech company ImClone Systems Inc., and, in the latest setback, earlier-than-expected competition for its top-selling Plavix drug.

If the Bristol-Myers board members decide to dismiss him, Dolan would be the third CEO of a large pharmaceutical company to lose his post.